This is another step in American Heart of Poland's expansion as part of its long-term strategy to support the development of Poland's public healthcare system. The AHP Group's goal is to increase its presence in new locations, as well as in new medical specialties oriented toward treating lifestyle diseases of an aging population. As part of the Scanmed Group's acquisition, American Heart of Poland will nearly double the size of its operations, which will particularly benefit the quality of patient treatment under the National Health Fund by coordinating patients in inpatient treatment, rehabilitation, diagnostics, outpatient specialty care, primary care and preventive programs. The AHP Group will also significantly increase its territorial reach, offering medical care to nearly 900,000 patients a year after the merger - as a result, it will manage facilities in 48 Polish cities, in 13 provinces.
For patients, this means improved access and quality provided by coordinated care, including, in particular, National Health Fund programs such as KOS-infarction, conducted, among others, as part of inpatient rehabilitation at Ustroń Health Resort, and a complementary range of medical services covering virtually all branches of medicine. Noteworthy, the AHP Group is making and will continue to make extensive investments in the infrastructure of public hospitals in the coming years, equalizing local communities' access to world-class medicine, provided free of charge under National Health Fund insurance.
- Our mission is to increase the availability and quality of medical services for patients under the National Health Service. With the acquisition of Scanmed Group, we can respond more effectively to patients' needs by coordinating the treatment process at our facilities across the country," says Adam Szlachta, CEO and CFO of AHP Group.
Approaching its 25th anniversary, American Heart of Poland is gradually increasing the number of its facilities - since 2022 it has managed a hospital in Drawsko Pomorskie, and since 2023 it has also managed a multiprofile hospital in Sztum. Taking control of the Scanmed Group is another important step in the implementation of American Heart of Poland's development strategy.
Scanmed Group, which was previously owned by a private equity fund managed by Abris Capital Partners, is a leading medical operator in terms of its range of services. Scanmed offers medical care in more than 30 locations to nearly 500,000 patients a year throughout Poland. Scanmed's operations include primary health care, outpatient specialized care and hospital treatment. Scanmed's operations include a network of cardiology centers, located in eight provinces, providing comprehensive diagnosis and hospital treatment of cardiovascular diseases in conservative cardiology, interventional cardiology and electrophysiology. Scanmed also operates four multi-specialty hospitals - St. Raphael's Hospital in Krakow, Rudolf Weigl Hospital in Blachownia, Vital Medic Hospital in Kluczbork and Ars Medical in Piła. Scanmed also includes three specialized single-profile hospitals: gastroenterology, ophthalmology and orthopedics. Scanmed Group's hospital operations are complemented by medical centers, offering patients access to primary care, modern diagnostics and outpatient specialized care.
Wojciech Łukawski, partner at Abris Capital Partners, added: It has been an honor to work with Scanmed's experienced managers and top-class medical team. We are very pleased both with the results of the transformation that Scanmed has undergone with the support of the Abris team, and with the fact that the Scanmed team will be able to continue the process of improving the quality of services provided to Polish patients using the experience and potential of American Heart of Poland and Gruppo San Donato, co-creating a leading European group in the healthcare sector.
American Heart of Poland, as part of the public health care system, provides patients at more than 20 medical centers with comprehensive, multi-specialty medical care, combining health education, prevention, diagnosis, treatment and rehabilitation for diseases of civilization. The Group provides more than 260,000 patients a year with access to high-end medical procedures, under contract with the National Health Fund. The Group's entities perform 73,000 hospitalizations per year, particularly related to coronary procedures, rhythm and conduction disorders and heart failure.
Gruppo San Donato is Italy's largest and Europe's leading private healthcare group, specializing in acute care, medical education and research. It operates 136 medical facilities, world-leading hospitals with teaching and research activities, the Vita Salute San Raffaele University in Milan with 22 master's programs and doctoral-level education, and medical research ranked among the top 10 in the world (according to medical research citations). Gruppo San Donato is also a pioneer in gene and cell therapy worldwide. GSD treats more than 5.8 million patients a year and has more than 28,000 employees.
GKSD manages a diversified portfolio of companies operating in Italy that generate added value for their stakeholders by leveraging their unique know-how. GKSD focuses on a wide range of sectors, including healthcare purchasing and consulting, real estate, engineering and energy.
Source: Press Release
